Stephen Daniells

ILSI Europe’s PRODARE framework introduces specific recommendations for designing and reporting human probiotic studies, addressing challenges unique to live microorganisms such as viability, strain identity, and dosage. Developed through expert consensus, the guidelines emphasize clear strain reporting, standardized outcome measures, risk management, and study registration to improve reliability, transparency, and reproducibility in probiotic research. The framework also encourages alignment with international initiatives to strengthen the scientific and regulatory impact of probiotic studies.

Health Canada has granted a Natural Product Number to Ixoreal Biomed’s SRI-81 Shatavari, a clinically validated root-only extract designed for women’s health, authorizing claims related to managing menopausal symptoms, supporting sexual arousal, and improving overall wellbeing. Distributed in Canada by CK Nutraceuticals, SRI-81 Shatavari is standardized to Shatavarin IV and total shatavarins, targeting women seeking natural options for menopause support. The approval provides supplement brands a compliant path for science-backed product formulation. Shatavari, known in Ayurveda as the “Queen of Herbs,” contains phytoestrogens and has a history of supporting female reproductive health.

Catch up with our weekly round-up of key news from across the Nutraverse.

The 9th Annual NutraIngredients USA Awards, held in Chicago on July 13, recognized outstanding innovation, market success, and research in the nutrition and dietary supplements industry. Winners were chosen by expert judges from a competitive field of finalists across categories such as Ingredient of the Year, Product of the Year, and Specialty Awards. The event highlighted the industry's leading contributors and promised further coverage of the winners.

Catch up with our weekly round-up of key news from across the Nutraverse.

A probiotic strain named A21041, isolated from a Chinese centenarian, was found to extend the lifespan of nematode worms by nearly 20% and significantly reduce fat accumulation, likely through its antioxidant and anti-inflammatory effects. The probiotic also upregulated genes linked to antioxidant activity and enriched beneficial metabolites while lowering proinflammatory factors. These findings suggest that microbiota from long-lived humans may offer promising candidates for promoting healthspan and longevity.

NutraIngredients is seeking innovative, consumer-facing start-ups in longevity, healthspan, biotech, or nutrition to participate in the Healthspan Innovators session at the Nutra Healthspan Summit in London. Eligible start-ups, founded within the past 10 years, with fewer than 20 employees and at Series A funding or earlier, can apply for the chance to pitch their company, gain industry exposure, and network with experts. Selected participants will receive a full delegate pass, a speaking slot, brand visibility, and editorial coverage. Winners must be available to attend the summit in person on November 10 and 11, 2026.

A randomized, double-blind, placebo-controlled trial found that daily supplementation with Lacticaseibacillus rhamnosus CRL 1505 significantly reduced the recurrence and total number of upper respiratory tract infections (URTI) in healthy adults compared to placebo. The probiotic group also had longer periods between infections and a lower need for over-the-counter medication, though no difference in salivary IgA levels or severity of each infection was observed. These findings expand the evidence for CRL 1505’s immune health benefits from children to adults and suggest its potential in supporting respiratory health.

Swedish CDMO Wellma has acquired Virun NutraBiosciences, marking its entry into the US and Irish markets and adding advanced nutrient delivery technologies to its portfolio. Virun, founded in 2003 by Philip Bromley and Nick Huang, is recognized for its innovation in emulsion and liposomal systems and holds over 100 patents. This acquisition is Wellma’s thirteenth overall and first in the US, supporting its rapid global expansion and enhancing its position in the nutraceutical sector. The partnership aims to leverage shared values and expertise to support customers’ growth in both Europe and the US.

Catch up with our weekly round-up of key news from across the Nutraverse.